Canada becomes the first G7 country to approve a generic version of semaglutide
7 hours ago
- #healthcare
- #Canada
- #pharmaceuticals
- Canada approved the first generic version of semaglutide in the G7, authorized by Health Canada.
- The generic, by Dr. Reddy's Laboratories, is for treating type 2 diabetes with similar safety and efficacy as the brand Ozempic.
- Health Canada is reviewing eight other generic submissions, with more approvals expected in upcoming weeks and months.
- Generic semaglutide is chemically equivalent and could lower costs for patients and the healthcare system by 45-90%.
- Health Canada conducts regular safety monitoring and reviews generic submissions within a 180-day target, quicker than many regulators.